Acknowledgments

The ChEMBL resources are made available due to funding from the following:

Current Awards

  • 2014-2019: Wellcome Trust (Strategic Award WT086151/Z/08/Z). The member states of EMBL

  • 2016-2022: European Commission Horizon 2020. Toxicity Testing and Risk Assessment in the 21st Century EU-ToxRisk (681002)

  • 2015-2019: Coordinated Research Infrastructures Building Enduring Life-science Services CORBEL (654248)

  • 2018-2023: Illuminating the Druggable Genome NIH grant 1U24CA224370-01

  • 2014-2020: Open Targets

  • 2013-2018: European Commission FP7 HeCaTos - Safety prediction (602156)

  • 2017-2022: European Commission/IMI2 eTRANSAFE - Enhacing TRANslational SAFEty Assessment through Integrative Knowledge Management (777365)

  • 2017-2021: European Commission/IMI2/TransQST - Translational quantitative systems toxicology to improve the understanding of the safety of medicines (116030)

Past Awards

  • 2009-2016: European Commission/IMI IMI eTox (115002)

  • 2014-2016: Illuminating the Druggable Genome NIH grant 1U54CA189205-01

  • 2008-2014: Chemogenomics at the EBI, WT Strategic award 086151/Z/08/Z

  • 2012-2015: European Commission FP7 BioMedBridges (284209)

  • 2014-2014: Pistoia Alliance Application of HELM Nomenclature to ChEMBL peptide content.

  • 2012-2014: Medicines for Malaria Ventures - Malaria Data Deposition Portal

  • 2012-2014: European Commission/IMI IMI Open PHACTS (115191)

  • 2011-2014: European Commission FP7 DiXa (283775)

  • 2011-2014: BBSRC/EPSRC/MRC SMSDrug.net - Chemical Biology Networking (EP/I037229/1)

  • 2013-2013: Syngenta - Herbicide and Insecticide Data for ChEMBL

  • 2011-2013: GSK - ADMET SARfari

  • 2009-2013: European Commission ESFRI EU-OpenScreen (261861)

  • 2010-2011: Pfizer - Druggability Analysis